Aveanna Healthcare Holdings, INC 8-K filings

Aveanna Healthcare reports significant revenue and adjusted EBITDA growth for Q4 and full year 2024, exceeding expectations and providing optimistic guidance for 2025.

Aveanna Healthcare's investor presentation outlines its strategic focus on value-based growth and enhanced capital structure, showcasing positive financial performance and operational improvements.

Aveanna Healthcare announced a 6.5% increase in third-quarter revenue and a 32.2% increase in adjusted EBITDA, leading to an improved full-year outlook.

Aveanna Healthcare has appointed Brent Layton, former President and COO of Centene Corporation, to its Board of Directors and Audit Committee, effective November 1, 2024.

Aveanna Healthcare has successfully amended its First Lien Credit Agreement, extending the maturity date of its revolving credit facility to April 2028 and adjusting borrowing availability.

Aveanna Healthcare's investor presentation outlines its growth strategy, financial performance, and focus on value-based care.

Aveanna Healthcare announced a 7.0% increase in second-quarter revenue and a 27.3% jump in adjusted EBITDA, leading to an improved full-year guidance.

Aveanna Healthcare Holdings Inc. has amended its receivables financing agreement, increasing the maximum available amount to $225 million.

Aveanna Healthcare's investor presentation outlines its growth strategy, financial performance, and focus on value-based care.

Aveanna Healthcare Holdings Inc. held its 2024 Annual Meeting of Stockholders on May 16, 2024, and has released the voting results for the proposals submitted to a vote.

Aveanna Healthcare presented its financial and operational highlights to investors, showcasing growth across its segments and a focus on value-based care.

Aveanna Healthcare announced a 5.2% increase in revenue and a 22.5% increase in Adjusted EBITDA for the first quarter of 2024, leading to an improved full-year outlook.

Aveanna Healthcare announced a 6.1% increase in fourth-quarter revenue and a 30.4% increase in adjusted EBITDA compared to the prior year, alongside a positive outlook for 2024.

Aveanna Healthcare's Chief Legal Officer, Shannon Drake, will depart on March 31, 2024, with a separation agreement including severance and equity vesting terms.